CollPlant Biotechnologies Debt-to-Equity Ratio Growth & History (CLGN)
CollPlant Biotechnologies's debt-to-equity ratio was 0.47 for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.47 | 0.24 | +104.54% |
| 2024 | 2024-12-31 | 0.23 | 0.12 | +105.27% |
| 2023 | 2023-12-31 | 0.11 | 0.01 | +11.33% |
| 2022 | 2022-12-31 | 0.10 | 0.01 | +17.13% |
| 2021 | 2021-12-31 | 0.09 | −0.67 | −88.74% |
| 2020 | 2020-12-31 | 0.76 | — | — |
| 2017 | 2017-12-31 | 0.39 | — | — |
CollPlant Biotechnologies quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 0.54 | 0.31 | +136.41% |
| Q4 2025 | 2025-12-31 | 0.47 | 0.24 | +104.54% |
| Q3 2025 | 2025-09-30 | 0.32 | — | — |
| Q2 2025 | 2025-06-30 | 0.24 | 0.08 | +48.23% |
| Q1 2025 | 2025-03-31 | 0.23 | — | — |
| Q4 2024 | 2024-12-31 | 0.23 | 0.12 | +105.27% |
| Q2 2024 | 2024-06-30 | 0.16 | 0.07 | +75.88% |
| Q4 2023 | 2023-12-31 | 0.11 | 0.01 | +11.33% |
| Q2 2023 | 2023-06-30 | 0.09 | 0.02 | +21.29% |
| Q4 2022 | 2022-12-31 | 0.10 | 0.01 | +17.13% |
| Q2 2022 | 2022-06-30 | 0.08 | 0.01 | +14.68% |
| Q4 2021 | 2021-12-31 | 0.09 | −0.67 | −88.74% |
| Q2 2021 | 2021-06-30 | 0.07 | −0.52 | −88.64% |
| Q4 2020 | 2020-12-31 | 0.76 | — | — |
| Q2 2020 | 2020-06-30 | 0.59 | −4.13 | −87.56% |
| Q2 2019 | 2019-06-30 | 4.72 | 4.71 | +28748.04% |
| Q2 2018 | 2018-06-30 | 0.02 | — | — |
CollPlant Biotechnologies debt-to-equity ratio trends
Over the last five fiscal years, CollPlant Biotechnologies's debt-to-equity ratio decreased from 0.76 to 0.47, a change of −0.29. The latest reported quarter, Q1 2026, shows 0.54.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗